The Nutrition Labeling and Education Act (NLEA) of 1990 authorized the U.S. Food & Drug Administration to require nutrient labeling on almost all foods sold domestically. While conflicting legislation has caused controversy as to whether medical marijuana infused edibles are constituted a food product or not, noncompliance with FDA regulations can carry stiff fines, detained product, and other penalties.
Anresco has performed nutritional labeling analyses since 1973 and has helped thousands of companies comply with FDA/USDA labeling regulations, using AOAC, FDA, USDA or equivalent recognized methods for all analyses. Leverage our expertise to navigate the changing regulatory requirements of the food industry.
Shelf Life Testing
Most perishable foods sold commercially in the United States undergo analytical testing to determine the life expectancy or “shelf life” of a product under normal storage conditions before excessive deterioration occurs. While not a mandatory requirement, determining shelf life is valuable for vendors to establish a time frame in which to safely sell their products. Similarly, providing consumers with an expiration date ensures that a product unfit for human consumption is not unintendedly ingested.
On Day 0 of a shelf life study, Anresco tests the product for Salmonella, Listeria, and Coliforms/E.Coli. If the product fails any of these tests, the rest of the shelf life study is discontinued.
Anresco will then perform then following tests at varying intervals:
- Standard Plate Count
- Yeast & Mold
Depending on the product and its expected viability, Anresco will recommend a proposed schedule (e.g. 7 days, 14 days, 21 days, etc.). This schedule may be altered by our Microbiology Department if they visualize noticeable changes to the product during the study. If the product fails at any point in time, all future scheduled testing dates are discontinued and not charged for.
Under the Bureau of Cannabis Control’s published regulations, edible cannabis products that contain more than one serving must undergo homogeneity testing every six months to confirm that cannabinoid dosing is accurate.
Homogeneity testing consists of testing multiple samples from the same product for potency, this ensures that cannabinoids are distributed evenly through the product.